Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Mar 2025 is 26.00% vs -13.79% in Mar 2024
Consolidate Net Profit
YoY Growth in quarter ended Mar 2025 is 133.33% vs -500.00% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Mar 2025 is 225.00% vs -500.00% in Mar 2024
Interest
YoY Growth in quarter ended Mar 2025 is -100.00% vs 0.00% in Mar 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Mar 2025 has improved from Mar 2024
Compare Quarterly Results Of Genomed SA With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2025 is -12.50% vs 28.57% in Dec 2024
YoY Growth in quarter ended Mar 2025 is 26.00% vs -13.79% in Mar 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2025 is -86.67% vs 275.00% in Dec 2024
YoY Growth in quarter ended Mar 2025 is 133.33% vs -500.00% in Mar 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2025 is -72.22% vs 200.00% in Dec 2024
YoY Growth in quarter ended Mar 2025 is 225.00% vs -500.00% in Mar 2024
Quarterly - Interest
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2025 has fallen from Dec 2024
YoY Growth in quarter ended Mar 2025 has improved from Mar 2024






